Sonomed's ophthalmic scans:
This article was originally published in Clinica
The Chinese FDA has approved Sonomed's PacScan and E/Z-Scan ophthalmic imaging products. Sonomed, a New York-based subsidiary of Escalon Medical, plans to market the products there immediately, through the Hwa-In Group and Shenzhen K&K, its existing distributors in China. The E/Z-Scan series, approved in the US in 2004, consists of B-scan and A/B-scan ultrasound systems, which are used to image and diagnose retinal and other conditions at the back of the eye. The PacScan series is made up of A-scans, pachymeters and combination systems used in cataract and refractive surgery. Pachymeters measure the thickness of the cornea and can also be used to screen patients suspected of developing glaucoma. Both systems are widely marketed internationally, Escalon said, but declined to give details of where.
You may also be interested in...
Under EU rules, once a medicinal product has been placed on the market in a country of the EEA – the EU plus Iceland, Liechtenstein and Norway
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.